Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-08-12 Sale | 2025-08-14 7:42 pm | Edgewise Therapeutics Inc. | EWTX | KOCH KEVIN President and CEO | 7,972 | $13.39 | $106,764 | 1,035,806 (Indirect Direct) | View |
| 2025-05-02 Sale | 2025-05-07 9:10 pm | Edgewise Therapeutics Inc. | EWTX | KOCH KEVIN President and CEO | 4,276 | $16.45 | $70,358 | 385,813 (Indirect Direct) | View |
| 2025-03-07 Sale | 2025-03-11 4:32 pm | Edgewise Therapeutics Inc. | EWTX | KOCH KEVIN President and CEO | 100 | $30 | $3,000 | 394,807 (Indirect Direct) | View |
| 2025-02-05 Sale | 2025-02-07 4:38 pm | Edgewise Therapeutics Inc. | EWTX | KOCH KEVIN President and CEO | 9,536 | $30.13 | $287,316 | 437,452 (Indirect Direct) | View |
| 2024-05-02 Sale | 2024-05-03 6:26 pm | Edgewise Therapeutics Inc. | EWTX | KOCH KEVIN President and CEO | 3,152 | $18.91 | $59,604 | 363,679 (Indirect Direct) | View |
| 2023-05-02 Sale | 2023-05-03 6:25 pm | Edgewise Therapeutics Inc. | EWTX | KOCH KEVIN President and CEO | 3,203 | $8.9049 | $28,522 | 366,831 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-08-12 Exercise | 2025-08-14 7:42 pm | N/A 2034-08-12 | Edgewise Therapeutics Inc. | EWTX | KOCH KEVIN President and CEO | 17,968 | $0 | 1,035,806 (Direct) | View |
| 2025-08-12 Option Award | 2025-08-14 7:42 pm | N/A 2035-08-12 | Edgewise Therapeutics Inc. | EWTX | KOCH KEVIN President and CEO | 612,500 | $0 | 1,035,806 (Direct) | View |
| 2025-05-01 Exercise | 2025-05-07 9:10 pm | 2025-05-01 2032-05-01 | Edgewise Therapeutics Inc. | EWTX | KOCH KEVIN President and CEO | 10,417 | $0 | 385,813 (Direct) | View |
| 2025-03-07 Exercise | 2025-03-11 4:32 pm | 2021-06-13 2027-08-08 | Edgewise Therapeutics Inc. | EWTX | KOCH KEVIN President and CEO | 100 | $0 | 394,807 (Direct) | View |
| 2025-03-07 Exercise | 2025-03-11 4:32 pm | N/A N/A | Edgewise Therapeutics Inc. | EWTX | KOCH KEVIN President and CEO | 100 | $0.18 | 394,807 (Direct) | View |
| 2025-02-05 Exercise | 2025-02-07 4:38 pm | 2021-06-13 2027-08-08 | Edgewise Therapeutics Inc. | EWTX | KOCH KEVIN President and CEO | 9,536 | $0 | 437,452 (Direct) | View |
| 2025-02-06 Exercise | 2025-02-07 4:38 pm | N/A N/A | Edgewise Therapeutics Inc. | EWTX | KOCH KEVIN President and CEO | 900 | $13.11 | 437,452 (Direct) | View |
| 2025-02-05 Exercise | 2025-02-07 4:38 pm | N/A N/A | Edgewise Therapeutics Inc. | EWTX | KOCH KEVIN President and CEO | 8,636 | $0.18 | 437,452 (Direct) | View |
| 2024-08-12 Option Award | 2024-08-14 4:14 pm | N/A 2034-08-12 | Edgewise Therapeutics Inc. | EWTX | KOCH KEVIN President and CEO | 503,125 | $0 | 503,125 (Direct) | View |
| 2024-05-01 Exercise | 2024-05-03 6:26 pm | N/A 2032-05-01 | Edgewise Therapeutics Inc. | EWTX | KOCH KEVIN President and CEO | 10,417 | $0 | 363,679 (Direct) | View |
| 2023-08-17 Option Award | 2023-08-18 7:12 pm | N/A 2033-08-17 | Edgewise Therapeutics Inc. | EWTX | KOCH KEVIN President and CEO | 600,000 | $0 | 600,000 (Direct) | View |
| 2023-05-01 Exercise | 2023-05-03 6:25 pm | N/A 2032-05-01 | Edgewise Therapeutics Inc. | EWTX | KOCH KEVIN President and CEO | 10,416 | $0 | 366,831 (Direct) | View |
| 2022-08-08 Option Award | 2022-08-10 5:41 pm | N/A 2032-08-08 | Edgewise Therapeutics Inc. | EWTX | KOCH KEVIN President and CEO | 550,000 | $0 | 550,000 (Direct) | View |
| 2022-05-01 Option Award | 2022-05-03 4:14 pm | N/A 2025-05-01 | Edgewise Therapeutics Inc. | EWTX | KOCH KEVIN President and CEO | 31,250 | $0 | 31,250 (Direct) | View |
| 2021-08-17 Option Award | 2021-08-19 5:09 pm | N/A 2031-08-17 | Edgewise Therapeutics Inc. | EWTX | KOCH KEVIN President and CEO | 400,000 | $0 | 400,000 (Direct) | View |
Ownership | 2021-03-25 9:38 pm | N/A N/A | Edgewise Therapeutics Inc. | EWTX | KOCH KEVIN President and CEO | 0 | $0 | 2,105,104 (Indirect) | View |